GUTS · Fractyl Health, Inc. · Documents
$1.33
-0.05 (-3.62%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, we have concluded that substantial doubt exists about our ability to continue as a going concern for at least one year after the date that these financial statements are issued.”View the 10-Q filed Aug 10, 2026
Market Cap
$17.64M
Shares
13.26M
Volume · Oct 20
477.96K
Avg daily vol (12 sessions)
1.54M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Fractyl Health reported topline six-month results from its REMAIN-1 Pivotal Cohort showing Revita met its co-primary endpoint with high statistical significance (p=0.0023), maintaining ~80% of GLP-1-induced weight loss versus 67% for sham. A De Novo FDA submission is planned for late Q4 2026. | 2026-10-16 | — | |
| 8-K | — | 2026-10-01 | 2026-09-30 | |
| 8-K | — | 2026-09-24 | — | |
| Investor Event Transcript | — | 2026-09-14 | 2026-09-30 | |
| 8-K | — | 2026-09-11 | 2026-09-10 | |
| DEF 14A | — | 2026-08-24 | — | |
| PRE 14A | — | 2026-08-14 | 2026-09-24 | |
| Investor Event Transcript | — | 2026-08-12 | 2026-09-30 | |
| 10-Q | — | 2026-08-10 | 2026-06-30 | |
| 8-K | — | 2026-08-10 | — | |
| 8-K | — | 2026-07-15 | — | |
| Investor Event Transcript | — | 2026-06-30 | — | |
| 8-K | — | 2026-06-11 | 2026-06-10 | |
| 8-K | — | 2026-06-04 | — | |
| 10-Q | — | 2026-05-12 | 2026-03-31 | |
| 8-K | — | 2026-05-12 | — | |
| 8-K | — | 2026-05-11 | — | |
| ARS | — | 2026-04-24 | 2025-12-31 | |
| DEFA14A | — | 2026-04-24 | — | |
| DEF 14A | — | 2026-04-24 | 2026-04-23 | |
| 10-K | — | 2026-03-24 | 2025-12-31 | |
| 8-K | — | 2026-03-24 | — | |
| 8-K | — | 2026-03-17 | 2026-03-13 | |
| 8-K | — | 2026-02-26 | — | |
| 8-K | — | 2026-01-29 | — | |
| 8-K | — | 2026-01-06 | 2025-12-30 | |
| 8-K | — | 2026-01-05 | — | |
| Investor Event Transcript | — | 2025-12-31 | — | |
| 8-K | — | 2025-12-16 | 2025-12-15 | |
| 8-K | — | 2025-12-02 | — | |
| 8-K | — | 2025-11-12 | — | |
| 10-Q | — | 2025-11-12 | 2025-09-30 | |
| 8-K | — | 2025-10-03 | — | |
| 8-K | — | 2025-09-26 | — | |
| 8-K | — | 2025-09-26 | — | |
| 8-K | — | 2025-09-03 | 2025-08-29 | |
| DEF 14A | — | 2025-08-25 | 2025-10-03 | |
| PRE 14A | — | 2025-08-15 | 2025-10-03 | |
| 8-K | — | 2025-08-12 | — | |
| 10-Q | — | 2025-08-12 | 2025-06-30 | |
| 8-K | — | 2025-08-07 | 2025-08-06 | |
| 8-K | — | 2025-06-23 | — | |
| 8-K | — | 2025-06-18 | — | |
| 8-K | — | 2025-06-12 | 2025-06-11 | |
| 8-K | — | 2025-05-19 | 2025-05-17 | |
| 8-K | — | 2025-05-19 | — | |
| 10-Q | — | 2025-05-13 | 2025-03-31 | |
| 8-K | — | 2025-05-13 | — | |
| DEFA14A | — | 2025-04-24 | — | |
| ARS | — | 2025-04-24 | 2024-12-31 |
Showing 1–50 of 74 filings